FigureĀ 2.
Cumulative incidence of thrombotic outcomes. Cumulative incidence of (A) progression/recurrence of SpVT and (B) usual-site VTE using the Kaplan-Meier method with death as a competing risk within 1 year of diagnosis of cancer-associated SpVT.